Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.340
-0.060 (-4.29%)
At close: Jun 13, 2025, 4:00 PM
1.330
-0.010 (-0.74%)
After-hours: Jun 13, 2025, 7:07 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $293.10 million as of June 13, 2025. Its market cap has decreased by -39.75% in one year.
Market Cap
293.10M
Enterprise Value
101.98M
1-Year Change
-39.75%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $293.10M, a decrease of -89.83%. That is a compound annual growth rate of -28.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 735.57B |
Johnson & Johnson | 377.99B |
Novo Nordisk | 355.28B |
AbbVie | 337.52B |
UnitedHealth Group | 284.42B |
Abbott Laboratories | 235.96B |
Novartis AG | 234.52B |
AstraZeneca | 231.58B |